Samantapudi Daya is a Cardiology physician affiliated with Boston Medical Center. OpenAlex indexes 20 publications with 1,190 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
811 W Interstate 20 Ste 224
Arlington, TX 760175873
Telephone
817-641-6000Provider last certified this registry record 26 Jan 2023.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kestra Medical Technology Services, Inc.Program year202516 payments
- ABIOMEDProgram year20254 payments
- Bard Peripheral Vascular, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.8%Beta blocker23%Metoprolol Succinate38%Atenolol21%Carvedilol16%Bisoprolol-Hydrochlorothiazide14%Metoprolol Tartrate9%Sotalol2%Part D<11 patientsAngiotensin receptor blocker (ARB)9.2%Losartan Potassium52%Valsartan22%Olmesartan Medoxomil11%Candesartan Cilexetil7%Losartan-Hydrochlorothiazide7%Part D<11 patients+ 17 more classes in this area
Blood & clotting
15.6%Factor Xa inhibitor11.9%Eliquis84%Xarelto16%Part D≥78 patientsP2Y12 inhibitor3.7%Clopidogrel100%Part D≥39 patientsMetabolism & gastrointestinal
2.9%Potassium supplement1.5%Potassium Chloride100%Part D≥19 patientsSGLT2 inhibitor0.8%Jardiance100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- OE-429 Cardiac Resynchronization Therapy Reverses Ionic Remodeling and Reduces Early Afterdepolarizations in a Canine Model of Dyssynchronous Heart Failure(OE72,Arrhythmia, Mechanism (A),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
Japanese Circulation Journal-english Edition
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Alice Jacobs, MD
Boston Medical Center
Carlos Kase, MD
Boston Medical Center
Sushrut Waikar, MD
Boston Medical Center
Geoffrey Oxnard, MD
Boston Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”